Tuberculosis Trial, Recruiting NCT06485895 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06485895
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old
  • People who are currently receiving treatment for tuberculosis (TB) disease
  • People who have had a specific type of TB screening blood test (called an IGRA test) ordered by a doctor, either already completed or currently being done
  • People who have been given information about the study and have not said they do not want to take part
  • People who speak French and can clearly understand spoken and written instructions in French

Who may not be able to join:

  • People who are currently taking part in another clinical study that restricts them from joining additional studies
  • Women who are pregnant, in labour, or currently breastfeeding
  • People who are in custody or detention, either by a court order or an administrative decision

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: François CREMIEUX, ASSISTANCE PUBLIQUE HOPITAUX D EMARSEILLE

Phone: 33+ 04 13 73 24 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 July 2024
Est. completion
30 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

sensitivity of TB-IGRA 2nd generation test; specificity of TB-IGRA 2nd generation test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov